Flindr Therapeutics
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $21M
Investors
- 8
About Flindr Therapeutics
, formerly known as Immagene, operates as a precision oncology therapeutics company. The firm is spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute and was founded by Maarten Ligtenberg (CEO), Daniel Peeper, and Christian Blank. Flindr Therapeutics develops first-in-class small-molecule inhibitors that can be used for the treatment of cancer. The company focuses on developing drugs to treat patients with specific genetic alterations. The firm’s product line includes an ImmunoGram drug discovery engine that develops small-molecule inhibitors of RNF31 (also known as HOIP), which is a protein-stabilizing E3 ubiquitin ligase.
Who invested in Flindr Therapeutics
8 investors across 2 rounds
See all investors in Flindr Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Flindr Therapeutics
Who invested in Flindr Therapeutics?
Flindr Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Flindr Therapeutics raised?
Flindr Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Flindr Therapeutics last raise money?
Flindr Therapeutics's most recent round on record is a Series A, in Apr 2024.
What does Flindr Therapeutics do?
, formerly known as Immagene, operates as a precision oncology therapeutics company.
Where is Flindr Therapeutics headquartered?
Flindr Therapeutics is headquartered in Netherlands.
Which VCs invest in companies like Flindr Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Flindr Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Flindr Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.